If you want to know who really controls eXoZymes, Inc. (NASDAQ:EXOZ), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company ...

Cash and Cash Equivalents: $3.04 million as of the end of December 2025. Total Operating Expenses: $9.72 million for the year 2025, an increase of $3.78 million from 2024. Net Loss: $9.16 million for ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

At close: 4 May at 4:00:00 pm GMT-4 Chart does not reflect overnight price.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

View eXoZymes Inc. EXOZ stock quote prices, financial information, real-time forecasts, and company news from CNN.

XoZymes ( (EXOZ)) has provided an announcement. On May 7, 2026, eXoZymes Inc., a Nevada corporation, circulated an investor presentation to potential underwriters, offering participants, and ...

Get the latest eXoZymes, Inc. (EXOZ) stock news and headlines to help you in your trading and investing decisions.

MONROVIA, CA - Invizyne Technologies, Inc., a company specializing in enzyme-based biomanufacturing systems, has announced its corporate rebranding to eXoZymes, Inc. The change will be reflected in ...

Get real-time EXoZymes (EXOZ) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to inform your investment decisions.

Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into ...